Three cases of mesalazine-induced pneumonitis with eosinophilia

Respir Investig. 2014 May;52(3):209-12. doi: 10.1016/j.resinv.2013.12.002. Epub 2014 Jan 13.

Abstract

Oral mesalazine, or 5-aminosalicylate, is one of the first-choice medications for the treatment of ulcerative colitis and is commonly used for both induction and maintenance therapy. In a 6-month period, we treated three cases of mesalazine-induced pneumonitis. In all three cases, computed tomography images revealed upper lobe dominant bilateral peripherally localized consolidations. Such images are commonly observed in patients with cryptogenic organizing pneumonia or chronic eosinophilic pneumonia. Computed tomography images for mesalazine-induced pneumonitis have been rarely reported in the literature.

Keywords: Adverse effects; Inflammatory bowel disease; Interstitial pneumonia; Ulcerative colitis.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Colitis, Ulcerative / drug therapy
  • Female
  • Humans
  • Lung / diagnostic imaging*
  • Mesalamine / administration & dosage
  • Mesalamine / adverse effects*
  • Middle Aged
  • Pneumonia / chemically induced*
  • Pneumonia / diagnostic imaging
  • Pneumonia / pathology
  • Pneumonia / therapy
  • Pulmonary Eosinophilia / chemically induced*
  • Pulmonary Eosinophilia / diagnostic imaging
  • Pulmonary Eosinophilia / pathology
  • Pulmonary Eosinophilia / therapy
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Mesalamine